Business Context and Reporting Period
This Form 8-K is a current report filed by Fluidigm Corporation (noted as Standard BioTools Inc. in metadata) on November 8, 2011. The filing serves to report the company's financial results for the three and nine months ended September 30, 2011, as detailed in a press release furnished as Exhibit 99.1.
Key Financial Metrics
The filing text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being contained within the attached press release (Exhibit 99.1), which is not included in the source text.
Material Changes
The filing text does not provide specific data regarding material changes versus prior comparable periods. It only confirms the issuance of results for the periods ended September 30, 2011.
Guidance, Outlook, and Risks
The filing text does not include management commentary, forward-looking guidance, specific risk factors, or details on contingencies and unusual items. The report explicitly states that the information furnished under Item 2.02 and the attached exhibit shall not be deemed "filed" for purposes of Section 18 of the Exchange Act or incorporated by reference, except as expressly set forth by specific reference.
Investor Verification Checklist
- Verify the specific revenue and net loss figures for the three and nine months ended September 30, 2011, by reviewing the attached press release (Exhibit 99.1).
- Confirm the company's cash position and burn rate as of the reporting date.
- Review the press release for any updated guidance or strategic shifts not detailed in this 8-K summary.
- Note that the financial data in this filing is not incorporated by reference into other SEC filings unless explicitly stated.